Stock listing

Curis, Inc.

Selected listing: A3ETJD · LS · EUR · DE

Curis, Inc. (Lang & Schwarz: A3ETJD), Health Technology. Latest release Sep 2, 2026: Caris Life Sciences to Present New Research Advancing Precision Oncology…

A3ETJD:LSEURDEUpdated September 25, 2026

Ticker: Lang & Schwarz: A3ETJD
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Curis, Inc.

Curis, Inc. (ticker: CRIS) is a public company operating in the American market. The company is dedicated to advancing its pipeline of drug candidates to address unmet medical needs in oncology.

Latest news from Curis, Inc.

Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer

September 2, 2026

Curis, Inc. Announces Pricing of $5.6 Million Public Offering

August 13, 2026

Curis Doses First Five Patients in TakeAim CLL Study

July 30, 2026

Curis Announces Positive Emavusertib Update

July 22, 2026

Curis Consents First Six Patients in TakeAim CLL Study

July 6, 2026

All Curis, Inc. news →

Events

Replays

Curis, Inc. (CRIS) Q1 2026 Earnings Call
Tue, May 12, 2026 · 04:30 PM ET
Watch
Curis, Inc. (CRIS) Q4 2025 Earnings Call
Thu, Mar 19, 2026 · 04:30 PM ET
Watch
Curis, Inc. (CRIS) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 04:30 PM ET
Watch

Research Curis, Inc.

Curis, Inc. company profile

View the public company page for Curis, Inc. on 6ix.

Curis, Inc. news

Read company news and market updates connected to Curis, Inc..

Curis, Inc. investor events

Find investor webinars, events, and replay context for Curis, Inc..